Evidence map›Paper›PMID 41248476›Full record

ReviewJournal of chemical information and modeling2025

Best Practices for Machine Learning-Assisted Protein Engineering.

Fabio Herrera-Rocha, David Medina-Ortiz, Fabian Mauz, Juergen Pleiss, Mehdi D Davari

Abstract readReview
In one paragraph

Review in Journal of chemical information and modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Anti-CRISPR-mediated continuous directed evolution of CRISPR-Cas9 in human cells.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fabio Herrera-RochaLeibniz-Institute of Plant Biochemistry, Department of Bioorganic Chemistry, Weinberg 3, D-06120 Halle, Germany.ORCID 0009-0001-7232-6443
David Medina-OrtizLeibniz-Institute of Plant Biochemistry, Department of Bioorganic Chemistry, Weinberg 3, D-06120 Halle, Germany.ORCID 0000-0002-8369-5746
Fabian MauzLeibniz-Institute of Plant Biochemistry, Department of Bioorganic Chemistry, Weinberg 3, D-06120 Halle, Germany.ORCID 0000-0003-4673-5494
Juergen PleissInstitute of Biochemistry, University of Stuttgart, Allmandring 31, D-70569 Stuttgart, Germany.ORCID 0000-0003-1045-8202
Mehdi D DavariLeibniz-Institute of Plant Biochemistry, Department of Bioorganic Chemistry, Weinberg 3, D-06120 Halle, Germany.ORCID 0000-0003-0089-7156

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data-driven modeling based on machine learning (ML) is becoming a central component of protein engineering workflows. This perspective presents the elements necessary to develop effective, reliable, and reproducible ML models, and a set of guidelines for ML developments for protein engineering. This includes a critical discussion of software engineering good practices for the development and evaluation of ML-based protein engineering projects, emphasizing supervised learning. These guidelines cover all of the necessary steps for ML development, from data acquisition to model deployment. Additionally, the present perspective provides practical resources for the implementation of the outlined guidelines. These recommendations are also intended to support editors and scientific journals in enforcing good practices in ML-based protein engineering publications, promoting high standards across the community. With this, the aim is to further contribute to improved ML transparency and credibility by easing the adoption of software engineering best practices into ML development for protein engineering. We envision that the wide adoption and continuous update of best practices will encourage informed use of ML on real-world problems related to protein engineering.

Indexed as

Machine LearningProtein EngineeringProteinsSoftwareProteins

Identifiers

PMID41248476
PMCPMC12735661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.